STERIS plc (STE) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

16/25

Growth 3 Margin 2 Expansion 4 Platform 2 Financial 5

latest quarter score

Earnings Reports

16
STERIS (STE) Q1 2027: $600M North Carolina Facility Signals Long-Term Chemistry Capacity Bet
August 06, 2026
19
STERIS (STE) Q3 2026: Tariff Impact Rises $10M as Service Outpaces Capital, Margin Pressures Persist
June 15, 2026
23
STERIS (STE) Q4 2026: $46M Tariff Headwind Fails to Slow Double-Digit EPS Growth Trajectory
May 12, 2026
21
STERIS (STE) Q2 2026: Service Revenue Jumps 13% as Margin Expansion Outpaces Tariff Headwinds
November 06, 2025
21
STE Q1 2026: Tariff Headwind Rises $15M as Healthcare and AST Margins Expand
August 07, 2025
25
STE Q4 2025: Tariffs Add $30M Headwind as Healthcare Backlog and Margin Expansion Drive 2026 Setup
July 03, 2025

Browse all companies